Biorelevant solubility of poorly soluble drugs: rivaroxaban, furosemide, papaverine and niflumic acid.
暂无分享,去创建一个
[1] B. Noszál,et al. Lipophilicity of zwitterions and related species: a new insight. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[2] A. Avdeef,et al. Biorelevant pK(a) (37 °C) predicted from the 2D structure of the molecule and its pK(a) at 25 °C. , 2011, Journal of pharmaceutical and biomedical analysis.
[3] J. Tack,et al. Intestinal drug solubility estimation based on simulated intestinal fluids: comparison with solubility in human intestinal fluids. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[4] Bernard Faller,et al. What is modulating solubility in simulated intestinal fluids? , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[5] J. Comer,et al. Study of pH-dependent solubility of organic bases. Revisit of Henderson-Hasselbalch relationship. , 2010, Analytica chimica acta.
[6] Na Sun,et al. Dissolution rate and apparent solubility of poorly soluble drugs in biorelevant dissolution media. , 2010, Molecular pharmaceutics.
[7] Li Di,et al. Drug-like property concepts in pharmaceutical design. , 2009, Current pharmaceutical design.
[8] Alex Avdeef,et al. Miniaturized Rotating Disk Intrinsic Dissolution Rate Measurement: Effects of Buffer Capacity in Comparisons to Traditional Wood’s Apparatus , 2008, Pharmaceutical Research.
[9] J. Dressman,et al. Dissolution Media Simulating Conditions in the Proximal Human Gastrointestinal Tract: An Update , 2008, Pharmaceutical Research.
[10] L. Di,et al. Drug-like Properties: Concepts, Structure Design and Methods: from ADME to Toxicity Optimization , 2008 .
[11] J. Comer,et al. Study of equilibrium solubility measurement by saturation shake-flask method using hydrochlorothiazide as model compound. , 2008, Journal of Pharmaceutical and Biomedical Analysis.
[12] A. Bauer-Brandl,et al. Thermodynamic properties of flufenamic and niflumic acids--specific and non-specific interactions in solution and in crystal lattices, mechanism of solvation, partitioning and distribution. , 2007, Journal of pharmaceutical and biomedical analysis.
[13] Manfred Kansy,et al. High throughput solubility measurement in drug discovery and development. , 2007, Advanced drug delivery reviews.
[14] J. Dressman,et al. Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compounds. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[15] Adalberto Pessoa,et al. Micellar solubilization of drugs. , 2005, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[16] L. Di,et al. Physicochemical profiling: overview of the screens. , 2004, Drug discovery today. Technologies.
[17] Lawrence X. Yu,et al. Feasibility studies of utilizing disk intrinsic dissolution rate to classify drugs. , 2004, International journal of pharmaceutics.
[18] Alex Avdeef,et al. Absorption and Drug Development: Solubility, Permeability, and Charge State , 2003 .
[19] Kin Yip Tam,et al. Multi-wavelength spectrophotometric determination of acid dissociation constants: a validation study , 2001 .
[20] R. Löbenberg,et al. Evaluation of Various Dissolution Media for Predicting In Vivo Performance of Class I and II Drugs , 1998, Pharmaceutical Research.
[21] Alex Avdeef,et al. Potentiometric pKa determination of water-insoluble compounds: validation study in methanol/water mixtures , 1997 .
[22] J. Crison,et al. A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.
[23] K. Takács-Novák,et al. Lipophilicity of amphoteric molecules expressed by the true partition coefficient , 1995 .
[24] A. Avdeef,et al. Determination of protonation macro- and microconstants and octanol/water partition coefficient of the antiinflammatory drug niflumic acid. , 1994, Journal of pharmaceutical and biomedical analysis.
[25] K. Takács-Novák,et al. Lipophilicity of antibacterial fluoroquinolones , 1992 .
[26] K. Takács-Novák. PHYSICOCHEMICAL PROFILING IN DRUG RESEARCH AND DEVELOPMENT , 2014 .
[27] M. Almukainzi,et al. Simulated Biological Fluids with Possible Application in Dissolution Testing , 2011 .